Unlikely to cause harm — often a labeling or packaging issue.
Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
| Brand name | TELMISARTAN AND AMLODIPINE |
| Generic name | TELMISARTAN AND AMLODIPINE |
| Active ingredient(s) | TELMISARTAN, AMLODIPINE BESYLATE |
| Distributed by / for | Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India |
| NDC | 0378-1075-93 |
| Full product label | Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93. |
| Recalling firm | Viatris, Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 21,620 30-count bottles |
| Recall initiated | 2026-10-01 |
| Report date | 2026-10-28 |
| Recall completed | — |
| Recall number | D-0049-2027 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Morgantown WV United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗